Guardant Health (NASDAQ:GH) 报告季度每股亏损$(0.62)，这比分析师一致预期的每股亏损$(0.74)高出16.22%。与去年同期每股亏损$(0.64)相比增长3.13%。公司报告季度销售额为$201.814M，比分析师一致预期的$192.141M超出5.03%。与去年同期销售额$155.054M相比增长30.16%。
以上内容来自Benzinga Earnings专栏，原文如下：
Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.74) by 16.22 percent. This is a 3.13 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $201.814 million which beat the analyst consensus estimate of $192.141 million by 5.03 percent. This is a 30.16 percent increase over sales of $155.054 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.